NI
The startup has developed an image analysis technology that automates the acquisition and assessment of magnetic resonance imaging (MRI) sequences, specifically targeting irregularly shaped tumors like glioblastoma. This technology enables healthcare practitioners to quickly evaluate disease status through digital images, improving diagnostic efficiency and patient management.
Updated 3 months ago
Funding
$7.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed an image analysis technology that automates the acquisition and assessment of magnetic resonance imaging (MRI) sequences, specifically targeting irregularly shaped tumors like glioblastoma. This technology enables healthcare practitioners to quickly evaluate disease status through digital images, improving diagnostic efficiency and patient management.